Finance

Lists
543321:BOM
Tatva Chintan Pharma Chem Ltd
₹1,690.00
+0.56%
(+9.45) 1D
Sep 9, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 543321...
Open
₹1,675.05
High
₹1,710.00
Low
₹1,663.45
Mkt. cap
39.53B
Avg. vol.
0.00
Volume
4.57K
Dividend
0.12%
Quarterly dividend
₹0.50
Ex-dividend date
Sep 12, 2025
P/E ratio
76.93
52-wk high
₹1,838.85
52-wk low
₹982.55
EPS
₹21.97
No. of employees
793
Open
₹1,675.05
High
₹1,710.00
Low
₹1,663.45
Mkt. cap
39.53B
Avg. vol.
0.00
Volume
4.57K
Dividend
0.12%
Quarterly dividend
₹0.50
Ex-dividend date
Sep 12, 2025
P/E ratio
76.93
52-wk high
₹1,838.85
52-wk low
₹982.55
EPS
₹21.97
No. of employees
793
News stories
From web sources and news partners
About Tatva Chintan Pharma Chem Ltd
CEO-
Employees793
Founded1996
Headquarters-
SectorSpeciality chemicals
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.24B
1.31B
1.34B
1.67B
Cost of goods sold
548.62M
551.45M
667.56M
752.91M
Cost of revenue
548.62M
551.45M
667.56M
752.91M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
149.47M
168.24M
187.87M
167.36M
Operating expense
554.92M
597.72M
462.20M
700.34M
Total operating expenses
1.10B
1.15B
1.13B
1.45B
Operating income
131.62M
164.17M
211.68M
217.30M
Other non operating income
10.08M
17.34M
-32.86M
27.80M
EBT including unusual items
136.63M
176.58M
168.48M
211.11M
EBT excluding unusual items
136.63M
176.58M
168.77M
224.29M
Income tax expense
37.46M
24.93M
65.27M
51.30M
Effective tax rate
27.42%
14.12%
38.74%
24.30%
Other operating expenses
314.92M
338.80M
176.78M
427.32M
Net income
99.17M
151.65M
103.21M
159.81M
Net profit margin
8.03%
11.55%
7.69%
9.57%
Earnings per share
4.24
6.49
4.41
7.26
Interest and investment income
-
-
4.52M
-
Interest expense
-5.07M
-4.93M
-12.05M
-20.81M
Net interest expenses
-5.07M
-4.93M
-7.53M
-20.81M
Depreciation and amortization charges
90.53M
90.68M
97.55M
105.66M
EBITDA
221.74M
230.48M
299.82M
309.42M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps